NEW YORK, Aug. 25, 2021 /PRNewswire/ — The epinephrine autoinjector market is set to grow by $ 1.37 bn, progressing at a CAGR of over 7.84% during 2021-2025. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. Some of the major vendors of the epinephrine autoinjector market in the healthcare industry include Adamis Pharmaceuticals Corp., ALK-Abello AS, Antares Pharma Inc., Bausch Health Companies Inc., BIOPROJET, Kaleo Inc., Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Viatris Inc.
Technavio offers in-depth market insights that assist global businesses to obtain growth opportunities.
Factors such as technological advances, and marketing strategies will offer immense growth opportunities. To leverage the current opportunities, market vendors must strengthen their foothold in the fast-growing segments, while maintaining their positions in the slow-growing segments. The epinephrine autoinjector market is concentrated, and the degree of concentration will accelerate during the forecast period.
Epinephrine Autoinjector Market 2021-2025: Segmentation
Epinephrine Autoinjector Market is segmented as below:
- North America
To learn more about the global trends impacting the future of market research, download a free sample:
Epinephrine Autoinjector Market 2021-2025: Vendor Analysis and Scope
To help businesses improve their market position, Technavio’s report provides a detailed analysis of around 25 vendors operating in the market.
The report also covers the following areas:
- Epinephrine Autoinjector Market size
- Epinephrine Autoinjector Market trends
- Epinephrine Autoinjector Market industry analysis
The epinephrine autoinjector market is concentrated, and the degree of concentration will accelerate. The increasing prevalence of allergies will offer immense growth opportunities. However, product recalls and regulatory issues will hamper the market growth.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Backed with competitive intelligence and benchmarking, our research reports on the epinephrine autoinjector market are designed to provide entry support, customer profile & M&As as well as go-to-market strategy support.
Related Reports on Health Care Include:
Fundus Cameras Market Report -The fundus cameras market has the potential to grow by USD 120.40 million during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 5.55%. Download a free sample report now.
Colonoscopy Devices Market Report -The colonoscopy devices market has the potential to grow by USD 536.78 million during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 5.06%.Download a free sample report now.
Epinephrine Autoinjector Market 2021-2025: Key Highlights
- CAGR of the market during the forecast period 2021-2025
- Detailed information on factors that will assist epinephrine autoinjector market growth during the next five years
- Estimation of the epinephrine autoinjector market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the epinephrine autoinjector market
- Analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of epinephrine autoinjector market vendors
Table of Contents:
- Market ecosystem
- Value chain analysis
- Market definition
- Market segment analysis
- Market size 2020
- Market outlook: Forecast for 2020 – 2025
Five Forces Analysis
- Five Forces Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Dosage
- Market segments
- Comparison by Dosage
- 0.30gm – Market size and forecast 2020-2025
- 0.15gm – Market size and forecast 2020-2025
- 0.50gm – Market size and forecast 2020-2025
- Market opportunity by Dosage
- Geographic segmentation
- Geographic comparison
- North America – Market size and forecast 2020-2025
- Europe – Market size and forecast 2020-2025
- Asia – Market size and forecast 2020-2025
- ROW – Market size and forecast 2020-2025
- Key leading countries
- Market opportunity by geography
- Market drivers
- Market challenges
- Market trends
- Vendor landscape
- Landscape disruption
- Vendors covered
- Market positioning of vendors
- Adamis Pharmaceuticals Corp.
- ALK-Abello AS
- Antares Pharma Inc.
- Bausch Health Companies Inc.
- kaleo Inc.
- Novartis AG
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
Technavio’s in-depth market research reports now include a thorough analysis of the COVID-19 impact on various markets to help industry leaders navigate their business through the new normal.
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
View original content to download multimedia:https://www.prnewswire.com/news-releases/-1-37-bn-growth-in-epinephrine-autoinjector-market–emerging-trends-company-risk-and-key-executives–technavio-301361955.html